i2o Therapeutics – Next Generation Biologics & Peptides
Intarcia. i2o Therapeutics is developing disruptive delivery platforms and medicines designed to transform patient outcomes..
Read Intarcia.com news digest here: view the latest Intarcia articles and content updates right away or get to their most visited pages. Intarcia.com is not yet rated by Alexa. It seems that Intarcia content is notably popular in USA, as 80.1% of all users (12K visits per month) come from this country. We haven’t detected security issues or inappropriate content on Intarcia.com and thus you can safely use it. Intarcia.com is hosted with Amazon.com, Inc. (United States) and its basic language is English.
Content verdict: Safe
Website availability: Live
Language: English
Last check:
-
489
Visitors daily -
977
Pageviews daily -
3
Google PR -
N/A
Alexa rank
Best pages on Intarcia.com
-
Intarcia Therapeutics, Inc. | Pipeline & Technology
FREEDOM CLINICAL PROGRAM FREEDOM is a global clinical trial development program made up of four Phase 3 studies collectively designed to assess whether the addition of ITCA 650 (continuous subcutaneou...
-
i2o Therapeutics – Next Generation Biologics & Peptides
i2o Therapeutics is developing disruptive delivery platforms and medicines designed to transform patient outcomes.
-
i2o Therapeutics – Next Generation Biologics & Peptides
An Unprecedented Opportunity GLP-1 Combinations for Obesity & Cardio-Renal-Metabolic Diseases Pipeline Assets Include: 2 Long-Acting GLP-1 RAs, 2 Long-Acting Amylin DACRAs, Long-Acting PYY RA & Long-A...
Domain history
| Web host: | Amazon.com, Inc. |
| Registrar: | Network Solutions, LLC |
| Registrant: | PERFECT PRIVACY, LLC |
| Updated: | February 24, 2025 |
| Expires: | May 22, 2025 |
| Created: | May 22, 2004 |
Whois record
Visitor gender
Male
Female
Safety scores
Trustworthiness
N/AChild safety
N/A
